Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Sinakos, Emmanouil [Clear All Filters]
Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma..
Scand J Gastroenterol. 45(4), 511-2.
(2010). Treatment options for primary sclerosing cholangitis..
Expert Rev Gastroenterol Hepatol. 4(4), 473-88.
(2010). Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels..
Ann Gastroenterol. 29(2), 208-13.
(2016). Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship..
Inflamm Bowel Dis. 19(5), 1004-9.
(2013). Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression..
Hepatology. 52(1), 197-203.
(2010). Focal nodular hyperplasia in an individual with Abernethy malformation type 1b..
Dig Liver Dis. 47(12), 1089.
(2015). Serum lipids in primary sclerosing cholangitis..
Dig Liver Dis. 44(1), 44-8.
(2012). Bile acid profiles in intrahepatic cholestasis of pregnancy: is this the solution to the enigma of intrahepatic cholestasis of pregnancy?.
Am J Gastroenterol. 105(3), 596-8.
(2010). Safety of deferasirox in sickle cell disease patients with co-existing liver impairment..
Br J Haematol. 157(4), 505-6; author reply 506-7.
(2012). Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma..
Clin Gastroenterol Hepatol. 9(5), 434-9.e1.
(2011). The significance of paired biopsies in estimating disease progression in patients with nonalcoholic steatohepatitis..
Eur J Gastroenterol Hepatol. 31(7), 897-898.
(2019). Is liver stiffness really unrelated to liver iron concentration?.
Br J Haematol. 150(2), 247-8.
(2010). The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence..
Ann Gastroenterol. 24(3), 228-230.
(2011). Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease..
Br J Haematol. 178(1), 130-136.
(2017).